| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Bioforum is a data focused CRO, offering a wide range of consulting services, medical writing, data management and bio-statistical support. We are a multi disciplinary team of experts that helps clients comprehend the value of their clinical data simply by making it readily available for monitoring, analysis and ready for submission. Adhering To The Highest Quality We simply don`t compromise on quality. Through our quality management system we ensure both processes and deliverables meet the industry standards and customer requirements. We implement high-quality practices in any project and task we perform and seek continuous improvement.
Patient Interaction is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cerebrio is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Family Counselling Centre is a Sarnia, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.